SEARCH

SEARCH BY CITATION

References

  • Abraira V. E., Hyun N., Tucker A. F., Coling D. E., Brown M. C., Lu C., Hoffman G. R. and Goodrich L. V. (2007) Changes in Sef levels influence auditory brainstem development and function. J. Neurosci. 27, 42734282.
  • Airaksinen M. S. and Saarma M. (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 3, 383394.
  • Alsina F. C., Irala D., Fontanet P. A., Hita F. J., Ledda F. and Paratcha G. (2012) Sprouty4 is an endogenous negative modulator of TrkA signaling and neuronal differentiation induced by NGF. PLoS ONE 7, e32087.
  • Arevalo J. C., Waite J., Rajagopal R., Beyna M., Chen Z. Y., Lee F. S. and Chao M. V. (2006) Cell survival through Trk neurotrophin receptors is differentially regulated by ubiquitination. Neuron 50, 549559.
  • Aruga J. and Mikoshiba K. (2003) Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth. Mol. Cell. Neurosci. 24, 117129.
  • Ascano M., Bodmer D. and Kuruvilla R. (2012) Endocytic trafficking of neurotrophins in neural development. Trends Cell Biol. 22, 266273.
  • Baquet Z. C., Gorski J. A. and Jones K. R. (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J. Neurosci. 24, 42504258.
  • Cabrita M. A. and Christofori G. (2008) Sprouty proteins, masterminds of receptor tyrosine kinase signaling. Angiogenesis 11, 5362.
  • Cattaneo A., Capsoni S. and Paoletti F. (2008) Towards non invasive nerve growth factor therapies for Alzheimer's disease. J. Alzheimers Dis. 15, 255283.
  • Chen Y., Aulia S., Li L. and Tang B. L. (2006) AMIGO and friends: an emerging family of brain-enriched, neuronal growth modulating, type I transmembrane proteins with leucine-rich repeats (LRR) and cell adhesion molecule motifs. Brain Res. Rev. 51, 265274.
  • Dawbarn D. and Allen S. J. (2003) Neurotrophins and neurodegeneration. Neuropathol. Appl. Neurobiol. 29, 211230.
  • Denayer E., Ahmed T., Brems H. et al. (2008) Spred1 is required for synaptic plasticity and hippocampus-dependent learning. J. Neurosci. 28, 1444314449.
  • Dikic I. and Giordano S. (2003) Negative receptor signalling. Curr. Opin. Cell Biol. 15, 128135.
  • Egan J. E., Hall A. B., Yatsula B. A. and Bar-Sagi D. (2002) The bimodal regulation of epidermal growth factor signaling by human Sprouty proteins. Proc. Natl Acad. Sci. USA 99, 60416046.
  • Friedman W. J. (2010) Proneurotrophins, seizures, and neuronal apoptosis. Neuroscientist 16, 244252.
  • Furthauer M., Lin W., Ang S. L., Thisse B. and Thisse C. (2002) Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling. Nat. Cell Biol. 4, 170174.
  • Garces A., Haase G., Airaksinen M. S., Livet J., Filippi P. and deLapeyriere O. (2000) GFRalpha 1 is required for development of distinct subpopulations of motoneuron. J. Neurosci. 20, 49925000.
  • Gensler M., Buschbeck M. and Ullrich A. (2004) Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1. J. Biol. Chem. 279, 1211012116.
  • Ghiglione C., Carraway K. L., 3rd, Amundadottir L. T., Boswell R. E., Perrimon N. and Duffy J. B. (1999) The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis. Cell 96, 847856.
  • Ghiglione C., Amundadottir L., Andresdottir M., Bilder D., Diamonti J. A., Noselli S., Perrimon N. and Carraway I. K. (2003) Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1. Development 130, 44834493.
  • Ginty D. D. and Segal R. A. (2002) Retrograde neurotrophin signaling: Trk-ing along the axon. Curr. Opin. Neurobiol. 12, 268274.
  • Gordon T. (2009) The role of neurotrophic factors in nerve regeneration. Neurosurg. Focus 26, E3.
  • Gross I., Armant O., Benosman S., de Aguilar J. L., Freund J. N., Kedinger M., Licht J. D., Gaiddon C. and Loeffler J. P. (2007) Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. Cell Death Differ. 14, 18021812.
  • Gur G., Rubin C., Katz M. et al. (2004) LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J. 23, 32703281.
  • Hackel P. O., Gishizky M. and Ullrich A. (2001) Mig-6 is a negative regulator of the epidermal growth factor receptor signal. Biol. Chem. 382, 16491662.
  • Hacohen N., Kramer S., Sutherland D., Hiromi Y. and Krasnow M. A. (1998) sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92, 253263.
  • Haglund K., Schmidt M. H., Wong E. S., Guy G. R. and Dikic I. (2005) Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation. EMBO Rep. 6, 635641.
  • Hedman H., Nilsson J., Guo D. and Henriksson R. (2002) Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol. 41, 352354.
  • Hollis E. R., 2nd, Jamshidi P., Low K., Blesch A. and Tuszynski M. H. (2009) Induction of corticospinal regeneration by lentiviral trkB-induced Erk activation. Proc. Natl Acad. Sci. USA 106, 72157220.
  • Holmlund C., Haapasalo H., Yi W., Raheem O., Brannstrom T., Bragge H., Henriksson R. and Hedman H. (2009) Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival. Neuropathology 29, 242247.
  • Impagnatiello M. A., Weitzer S., Gannon G., Compagni A., Cotten M. and Christofori G. (2001) Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells. J. Cell Biol. 152, 10871098.
  • Inoue H., Lin L., Lee X. et al. (2007) Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc. Natl Acad. Sci. USA 104, 1443014435.
  • Ishida M., Ichihara M., Mii S. et al. (2007) Sprouty2 regulates growth and differentiation of human neuroblastoma cells through RET tyrosine kinase. Cancer Sci. 98, 815821.
  • Katayama K., Zine A., Ota M., Matsumoto Y., Inoue T., Fritzsch B. and Aruga J. (2009) Disorganized innervation and neuronal loss in the inner ear of Slitrk6-deficient mice. PLoS ONE 4, e7786.
  • Kim D. and Dressler G. R. (2007) PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney. Dev. Biol. 307, 290299.
  • Kovalenko D., Yang X., Nadeau R. J., Harkins L. K. and Friesel R. (2003) Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation. J. Biol. Chem. 278, 1408714091.
  • Kramer S., Okabe M., Hacohen N., Krasnow M. A. and Hiromi Y. (1999) Sprouty: a common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126, 25152525.
  • Kramer E. R., Knott L., Su F., Dessaud E., Krull C. E., Helmbacher F. and Klein R. (2006) Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb. Neuron 50, 3547.
  • Kramer E. R., Aron L., Ramakers G. M., Seitz S., Zhuang X., Beyer K., Smidt M. P. and Klein R. (2007) Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biol. 5, e39.
  • Krig S. R., Frietze S., Simion C. et al. (2011) Lrig1 is an estrogen-regulated growth suppressor and correlates with longer relapse-free survival in ERalpha-positive breast cancer. Mol. Cancer Res. 9, 14061417.
  • Laederich M. B., Funes-Duran M., Yen L., Ingalla E., Wu X., Carraway K. L., 3rd and Sweeney C. (2004) The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J. Biol. Chem. 279, 4705047056.
  • Ledda F. and Paratcha G. (2007) Negative regulation of receptor tyrosine kinase (RTK) signaling: a developing field. Biomark. Insights 2, 4558.
  • Ledda F., Bieraugel O., Fard S. S., Vilar M. and Paratcha G. (2008) Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF. J. Neurosci. 28, 3949.
  • Lin W., Jing N., Basson M. A., Dierich A., Licht J. and Ang S. L. (2005) Synergistic activity of Sef and Sprouty proteins in regulating the expression of Gbx2 in the mid-hindbrain region. Genesis 41, 110115.
  • Lindvall O. and Wahlberg L. U. (2008) Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson's disease? Exp. Neurol. 209, 8288.
  • Liu K., Lu Y., Lee J. K. et al. (2010) PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 13, 10751081.
  • Lo K. Y., Chin W. H., Ng Y. P., Cheng A. W., Cheung Z. H. and Ip N. Y. (2005) SLAM-associated protein as a potential negative regulator in Trk signaling. J. Biol. Chem. 280, 4174441752.
  • Lu Y., Lin Y. Z., LaPushin R. et al. (1999) The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 18, 70347045.
  • Mandai K., Guo T., St Hillaire C., Meabon J. S., Kanning K. C., Bothwell M. and Ginty D. D. (2009) LIG family receptor tyrosine kinase-associated proteins modulate growth factor signals during neural development. Neuron 63, 614627.
  • Mason J. M., Morrison D. J., Basson M. A. and Licht J. D. (2006) Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling. Trends Cell Biol. 16, 4554.
  • McCall J., Weidner N. and Blesch A. (2012) Neurotrophic factors in combinatorial approaches for spinal cord regeneration. Cell Tissue Res. 349, 2737.
  • Mi S., Miller R. H., Lee X. et al. (2005) LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 8, 745751.
  • Mi S., Hu B., Hahm K., Luo Y., Kam Hui E. S., Yuan Q., Wong W. M., Wang L., Su H., Chu T. H., Guo J., Zhang W., So K. F., Pepinsky B., Shao Z., Graff C., Garber E., Jung V., Wu E. X. and Wu W. (2007) LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 13, 12281233.
  • Mi S., Miller R. H., Tang W. et al. (2009) Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann. Neurol. 65, 304315.
  • Nilsson J., Vallbo C., Guo D., Golovleva I., Hallberg B., Henriksson R. and Hedman H. (2001) Cloning, characterization, and expression of human LIG1. Biochem. Biophys. Res. Commun. 284, 11551161.
  • Panagiotaki N., Dajas-Bailador F., Amaya E., Papalopulu N. and Dorey K. (2010) Characterisation of a new regulator of BDNF signalling, Sprouty3, involved in axonal morphogenesis in vivo. Development 137, 40054015.
  • Pante G., Thompson J., Lamballe F., Iwata T., Ferby I., Barr F. A., Davies A. M., Maina F. and Klein R. (2005) Mitogen-inducible gene 6 is an endogenous inhibitor of HGF/Met-induced cell migration and neurite growth. J. Cell Biol. 171, 337348.
  • Paratcha G. and Ledda F. (2008) GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci. 31, 384391.
  • Patel T. D., Kramer I., Kucera J., Niederkofler V., Jessell T. M., Arber S. and Snider W. D. (2003) Peripheral NT3 signaling is required for ETS protein expression and central patterning of proprioceptive sensory afferents. Neuron 38, 403416.
  • Phoenix T. N. and Temple S. (2010) Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure. Genes Dev. 24, 4556.
  • Powell A. E., Wang Y., Li Y. et al. (2012) The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149, 146158.
  • Preger E., Ziv I., Shabtay A., Sher I., Tsang M., Dawid I. B., Altuvia Y. and Ron D. (2004) Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity. Proc. Natl Acad. Sci. USA 101, 12291234.
  • Proenca C. C., Gao K. P., Shmelkov S. V., Rafii S. and Lee F. S. (2011) Slitrks as emerging candidate genes involved in neuropsychiatric disorders. Trends Neurosci. 34, 143153.
  • Reichardt L. F. (2006) Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 15451564.
  • Ruberti F., Capsoni S., Comparini A., Di Daniel E., Franzot J., Gonfloni S., Rossi G., Berardi N. and Cattaneo A. (2000) Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J. Neurosci. 20, 25892601.
  • Rubin C., Litvak V., Medvedovsky H., Zwang Y., Lev S. and Yarden Y. (2003) Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops. Curr. Biol. 13, 297307.
  • Sasaki A., Taketomi T., Wakioka T., Kato R. and Yoshimura A. (2001) Identification of a dominant negative mutant of Sprouty that potentiates fibroblast growth factor- but not epidermal growth factor-induced ERK activation. J. Biol. Chem. 276, 3680436808.
  • Shattuck D. L., Miller J. K., Laederich M., Funes M., Petersen H., Carraway K. L., 3rd and Sweeney C. (2007) LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy. Mol. Cell. Biol. 27, 19341946.
  • Shen H., Chung J. M. and Chung K. (1999) Expression of neurotrophin mRNAs in the dorsal root ganglion after spinal nerve injury. Brain Res. Mol. Brain Res. 64, 186192.
  • Song W., Volosin M., Cragnolini A. B., Hempstead B. L. and Friedman W. J. (2010) ProNGF induces PTEN via p75NTR to suppress Trk-mediated survival signaling in brain neurons. J. Neurosci. 30, 1560815615.
  • Sun F. and He Z. (2010) Neuronal intrinsic barriers for axon regeneration in the adult CNS. Curr. Opin. Neurobiol. 20, 510518.
  • Tanabe K., Bonilla I., Winkles J. A. and Strittmatter S. M. (2003) Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J. Neurosci. 23, 96759686.
  • Teng K. K., Felice S., Kim T. and Hempstead B. L. (2010) Understanding proneurotrophin actions: Recent advances and challenges. Dev. Neurobiol. 70, 350359.
  • Thien C. B. and Langdon W. Y. (2005) c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochem. J. 391, 153166.
  • Torii S., Kusakabe M., Yamamoto T., Maekawa M. and Nishida E. (2004) Sef is a spatial regulator for Ras/MAP kinase signaling. Dev. Cell 7, 3344.
  • Tsang M. and Dawid I. B. (2004) Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci. STKE 2004, pe17.
  • Wakioka T., Sasaki A., Kato R., Shouda T., Matsumoto A., Miyoshi K., Tsuneoka M., Komiya S., Baron R. and Yoshimura A. (2001) Spred is a Sprouty-related suppressor of Ras signalling. Nature 412, 647651.
  • Wang B., Han L., Chen R., Cai M., Han F., Lei T. and Guo D. (2009) Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro. Cancer Biol. Ther. 8, 10181023.
  • Wendland J. R., Kruse M. R. and Murphy D. L. (2006) Functional SLITRK1 var321, varCDfs and SLC6A4 G56A variants and susceptibility to obsessive-compulsive disorder. Mol. Psychiatry 11, 802804.
  • Wickramasinghe S. R., Alvania R. S., Ramanan N., Wood J. N., Mandai K. and Ginty D. D. (2008) Serum response factor mediates NGF-dependent target innervation by embryonic DRG sensory neurons. Neuron 58, 532545.
  • Wong E. S., Lim J., Low B. C., Chen Q. and Guy G. R. (2001) Evidence for direct interaction between Sprouty and Cbl. J. Biol. Chem. 276, 58665875.
  • Wong V. W., Stange D. E., Page M. E. et al. (2012) Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat. Cell Biol. 14, 401408.
  • Ye F., Gao Q., Xu T. et al. (2009) Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity. J. Neurooncol. 94, 183194.
  • Yi W., Holmlund C., Nilsson J., Inui S., Lei T., Itami S., Henriksson R. and Hedman H. (2011) Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1. Exp. Cell Res. 317, 504512.
  • Zhang X., Pickin K. A., Bose R., Jura N., Cole P. A. and Kuriyan J. (2007) Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 450, 741744.